i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Continuous ventilation during intubation through a supraglottic airway device guided by fiberoptic bronchoscopy: a observational assessment

Landsdalen HE, Berge M, Kristensen F, Guttormsen AB, Søfteland E. Acta Anaesthesiol Scand. 2017 Jan;61(1):23-30 

An observational study using Tracheal intubation Assisted by Bronchoscopy And Sad during Continuous Oxygenation (TABASCO) method through the i-gel. Easy intubation was secured in all patients with no adverse events recorded.

Link to abstract

 

LMA ProSeal® vs. i-Gel® in ventilated children: A randomised, crossover study using the size 2 mask

Gasteiger L, Brimacombe J, Oswald E, Perkhofer D, Tonin A, Keller C, Tiefenthaler W. Acta Anaesthesiol Scand 2012; 56(10): 1321-1324

Fifty-one children aged 1.5-6 years, weighing 10-25kg, were studied randomly using either the size 2 LMA ProSeal® or i-gel®. The hypothesis tested was that oropharyngeal leak pressure and fiberoptic position of the airway tube differ between the two devices, with results proving similar.

Link to abstract.

The i-gel®, a single-use supraglottic airway device with a non-inflatable cuff and an esophageal vent: An observational study in children

Beylacq L, Bordes M, Semjen F, Cros AM. Acta Anaesthesiol Scand 2009; 53(3): 376-379

This study evaluated the i-gel® in 50 children above 30kg undergoing short-duration surgery. The parameters measured included: ease of insertion, seal pressure, ease of inserting a gastric tube and post operative complications. The first time insertion success rate was 100%. No laryngeal leak occurred. The mean seal pressure was 24.9cm H20. The authors concluded that i-gel® was very easy to insert and that ‘no learning curve is needed before a high success insertion rate is obtained. The i-gel® appears to be safe for paediatric management’.

Link to abstract.